Christie Medical Holdings, a US company has tied up with Alliance Transfusion as its distributor in India for the VeinViewer vascular imaging device s . VeinViewer is a hand-held vein illuminator that uses harmless near-infrared light and other technologies to project a real-time digital vein image directly onto the surface of the skin. VeinViewer displays vasculature and blood patterns up to 10 mm deep offers features like durability and portability to healthcare professionals.
The new model, VeinViewer Flex, first introduced in the US market in late 2011, will now be available in India as well. The VeinViewer vascular imaging device won the Medical Design Excellence Award (MDEA) in 2011 in New York, for medical design and innovation. The MDEA competition contributions and advances in the design of medical products. Entries are evaluated on the basis of the design and engineering features, including innovative use of materials, user-related functions that improve traditional medical practices and the ability of the product development team to overcome design and engineering challenges so that the product meets its clinical objectives.
VeinViewer is the only direct-projection vein illumination device clinically proven to improve peripheral vascular access while reducing the number of sticks and greatly improving patient satisfaction. Flex offers a customisable set of features through VeinViewer’s ASSESS imaging suite, as well as capabilities of digital real-time imaging via active vascular imaging navigation (AVIN).
VeinViewer provides a number of benefits to practitioners and patients, from easing the process during a paediatric blood draw to improving vascular access for a cancer patient. Patients and practitioners will see improvement in vascular access procedures, patient outcomes and cost savings. VeinViewer also increases successful vascular access, reduces pain and increases patient satisfaction. Among the benefits that practitioners can expect are improvements in patient throughput; a reduction in secondary procedures and treatment delays and an increase in referrals and revenue.
EH News Bureau
- Advertisement -
